Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yariv Greenshpan

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|July 9, 2022
The Contribution of the Minimal Promoter Element to the Activity of Synthetic Promoters Mediating CAR Expression in the Tumor MicroenvironmentYariv Greenshpan, Omri Sharabi, Ksenia M Yegodayev, et al.
Oncotarget|January 10, 2018
<i>Neat1</i> in hematopoietic stem cellsNoam Fallik, Yael Bar-Lavan, Yariv Greenshpan, et al.
Molecules (Basel, Switzerland)|October 24, 2020
Engineering Stem Cell Factor Ligands with Different c-Kit Agonistic PotenciesTal Tilayov, Tal Hingaly, Yariv Greenshpan, et al.
Leukemia|July 26, 2018
Identification of immune-activated hematopoietic stem cellsNir Bujanover, Oron Goldstein, Yariv Greenshpan, et al.
Stem Cell Reports|January 3, 2017
Mapping Whole-Transcriptome Splicing in Mouse Hematopoietic Stem CellsOron Goldstein, Karin Meyer, Yariv Greenshpan, et al.
Scientific Reports|May 3, 2022
High throughput screen for the improvement of inducible promoters for tumor microenvironment cuesOmri Sharabi, Yariv Greenshpan, Noa Ofir, et al.
Communications Biology|January 30, 2021
Synthetic promoters to induce immune-effectors into the tumor microenvironmentYariv Greenshpan, Omri Sharabi, Aner Ottolenghi, et al.
Frontiers in Cellular and Infection Microbiology|March 27, 2020
N-Glycans Mediate the Ebola Virus-GP1 Shielding of Ligands to Immune Receptors and Immune EvasionMuhammed Iraqi, Avishay Edri, Yariv Greenshpan, et al.
Plos One|August 2, 2022
Nanocomposite coatings for the prevention of surface contamination by coronavirusEsti Toledo, Sharon Dim, Avishay Edri, et al.
International Journal of Molecular Sciences|May 14, 2022
Blocking the PCNA/NKp44 Checkpoint to Stimulate NK Cell Responses to Multiple MyelomaMuhammed Iraqi, Avishay Edri, Yariv Greenshpan, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|July 9, 2022
The Contribution of the Minimal Promoter Element to the Activity of Synthetic Promoters Mediating CAR Expression in the Tumor MicroenvironmentYariv Greenshpan, Omri Sharabi, Ksenia M Yegodayev, et al.
Oncotarget|January 10, 2018
<i>Neat1</i> in hematopoietic stem cellsNoam Fallik, Yael Bar-Lavan, Yariv Greenshpan, et al.
Molecules (Basel, Switzerland)|October 24, 2020
Engineering Stem Cell Factor Ligands with Different c-Kit Agonistic PotenciesTal Tilayov, Tal Hingaly, Yariv Greenshpan, et al.
Leukemia|July 26, 2018
Identification of immune-activated hematopoietic stem cellsNir Bujanover, Oron Goldstein, Yariv Greenshpan, et al.
Stem Cell Reports|January 3, 2017
Mapping Whole-Transcriptome Splicing in Mouse Hematopoietic Stem CellsOron Goldstein, Karin Meyer, Yariv Greenshpan, et al.
Scientific Reports|May 3, 2022
High throughput screen for the improvement of inducible promoters for tumor microenvironment cuesOmri Sharabi, Yariv Greenshpan, Noa Ofir, et al.
Communications Biology|January 30, 2021
Synthetic promoters to induce immune-effectors into the tumor microenvironmentYariv Greenshpan, Omri Sharabi, Aner Ottolenghi, et al.
Frontiers in Cellular and Infection Microbiology|March 27, 2020
N-Glycans Mediate the Ebola Virus-GP1 Shielding of Ligands to Immune Receptors and Immune EvasionMuhammed Iraqi, Avishay Edri, Yariv Greenshpan, et al.
Plos One|August 2, 2022
Nanocomposite coatings for the prevention of surface contamination by coronavirusEsti Toledo, Sharon Dim, Avishay Edri, et al.
International Journal of Molecular Sciences|May 14, 2022
Blocking the PCNA/NKp44 Checkpoint to Stimulate NK Cell Responses to Multiple MyelomaMuhammed Iraqi, Avishay Edri, Yariv Greenshpan, et al.
Pageof 2